Please assess the completion status of the following clinical trial:

Trial Title: Analgesic Ointment on Temporomandibular Joint and Masticatory Muscle Pain

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Self report of facial ache or pain in the muscles of mastication, the TMJ, or the region in front of ear or inside the ear~2. Positive clinical diagnosis of TMDs. The TMD diagnosis is classified using axis I of the research diagnostic criteria ( RDC) for TMDs. The RDC diagnosis consists of joint pain at rest ( spontaneous pain) and evoked pain (hyperalgesia) on palpation of the TMJ, TMJ reduction consists of reciprocal clicking or joint noise with mandibular movement examination.~3. For joint pain complaint, subjects will be required to have a self-report of at least 1 month of daily or nearly-daily pain.~4. Subjects with myogenic pain will be included if they meet inclusion and exclusion criteria since patients with TMDs are known to exhibit muscle pain secondary to their joint dysfunction.~Exclusion Criteria:~1. Subjects with infectious arthritis, crystal induced arthropathies, musculoskeletal disorders, subjects with a primary diagnosis of myofascial pain based on the RDC;~2. Subjects with pain attributable to confirmed migraine or head pain condition other than tension headache;~3. Subjects with acute infection or other significant disease of teeth, ears, eyes, nose or throats; subjects with untreated depressive disorder or not on stable antidepressant medication for more than 6 months;~4. Subjects with dental diseases that required ongoing treatment, which would confound the evaluation of orofacial pain;~5. Subjects who are not competent in giving consents.~6. Pregnant or lactating women~7. Subjects with sensitivity to the ingredient of Ping On Ointment will be excluded.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Ping On Ointment (Type: EXPERIMENTAL): Ping On Ointment
- Vaseline (Type: PLACEBO_COMPARATOR): Vaseline with minor trace of Ping On ointment to give medicinal smell

Based on this trial design, predict the completion outcome and termination type (if applicable).